Feasibility Study Using Zone-MPC Controller (Zone-Model Predictive Control) and Health Monitoring System (HMS)
Artificial Pancreas Device Feasibility Study for Type 1 Diabetes Patients Using Model-predictive Control and Health Monitoring System Algorithms With an Approved Subcutaneous Insulin Delivery Pump and Subcutaneous Continuous Glucose Monitor
Sponsor: Sansum Diabetes Research Institute
This EARLY_PHASE1 trial investigates Type 1 Diabetes Mellitus and is currently completed. Sansum Diabetes Research Institute leads this study, which shows 8 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Oct 2021 — Jul 2024 [monthly]
Completed EARLY_PHASE1
Status: Unknown Status → Completed
-
Jan 2021 — Oct 2021 [monthly]
Unknown Status EARLY_PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status EARLY_PHASE1
▶ Show 3 earlier versions
-
Feb 2018 — Jun 2018 [monthly]
Unknown Status EARLY_PHASE1
-
Feb 2017 — Feb 2018 [monthly]
Unknown Status EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status Phase 0
First recorded
Nov 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sansum Diabetes Research Institute
- University of California, Santa Barbara
For direct contact, visit the study record on ClinicalTrials.gov .